The Metabolic Topography of Parkinsonism

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  1994-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/jcbfm.1994.99PMID 8063874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.

  1994cited by this paper
• MPTP neurotoxicity to cerebellar Purkinje cells in mice.

  1993cited by this paper
• Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease

  1993cited by this paper
• Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.

  1993cited by this paper
• Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.

  1993cited by this paper
• Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease.

  1993cited by this paper
• Imaging cerebral function

  1993cited by this paper
• Functional Connectivity: The Principal-Component Analysis of Large (PET) Data Sets

  1993cited by this paper
• Superpett 3000 time-of-flight PET tomograph: optimization of factors affecting quantitation

  1993cited by this paper
• The detection of preclinical Parkinson's disease: What is the role of positron emission tomography?

  1993cited by this paper
• Topographical variation of the human primary cortices: implications for neuroimaging, brain mapping, and neurobiology.

  1993cited by this paper
• Neuropathology of Parkinson's disease and related syndromes.

  1992cited by this paper
• Potential Language and Attentional Networks Revealed through Factor Analysis of rCBF Data Measured with SPECT

  1992cited by this paper
• The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism.

  1992cited by this paper
• Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine

  1992cited by this paper
• A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.

  1992cited by this paper
• Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study

  1992cited by this paper
• Positron emission tomography studies in parkinsonism.

  1992cited by this paper
• Somatotopic mapping of the primary motor cortex in humans: activation studies with cerebral blood flow and positron emission tomography.

  1991cited by this paper
• A Regional Covariance Approach to the Analysis of Functional Patterns in Positron Emission Tomographic Data

  1991cited by this paper
• Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.

  1991cited by this paper
• The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.

  1991cited by this paper
• Detection of preclinical Parkinson's disease with PET

  1991cited by this paper
• Effects of Percent Thresholding on the Extraction of [18F]Fluorodeoxyglucose Positron Emission Tomographic Region-of-Interest Data

  1991cited by this paper
• Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest.

  1990cited by this paper
• Regional Cerebral Blood Flow in Mood Disorders I. Comparison of Major Depressives and Normal Controls at Rest

  1990cited by this paper
• Striatonigral degeneration. A clinicopathological study.

  1990cited by this paper
• Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP

  1990cited by this paper
• A hypothesis on the pathophysiological mechanisms that underlie levodopa‐ or dopamine agonist‐induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment

  1990cited by this paper
• An estimate of the incidence of dementia in idiopathic Parkinson's disease

  1990cited by this paper
• The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

  1990cited by this paper
• Cortical glucose metabolism in parkinson's and alzheimer's disease

  1990cited by this paper
• Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268

  1990cited by this paper
• A large scale manual production of [18F]FDG using a synthetic unit made of sterile disposable components and operated by a master slave manipulator

  1990cited by this paper
• Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.

  1989cited by this paper
• Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration

  1989cited by this paper
• Enhanced Detection of Focal Brain Responses Using Intersubject Averaging and Change-Distribution Analysis of Subtracted PET Images

  1988cited by this paper
• The metabolic anatomy of paraneoplastic cerebellar degeneration

  1988cited by this paper
• Scaled Subprofile Model: A Statistical Approach to the Analysis of Functional Patterns in Positron Emission Tomographic Data

  1987cited by this paper
• The metabolic pathology of the AIDS dementia complex

  1987cited by this paper
• Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.

  1987cited by this paper
• Positron emission tomography in Alzheimer's disease

  1986cited by this paper
• Regional blood flow in herniparkinsonism

  1985cited by this paper
• Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey.

  1985cited by this paper
• Relations between Neuropsychological and Cerebral Metabolic Asymmetries in Early Alzheimer's Disease

  1985cited by this paper
• Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease

  1985cited by this paper
• Regional blood flow in hemiparkinsonism.

  1985cited by this paper
• Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method

  1984cited by this paper
• Cortical abnormalities in Alzheimer's disease

  1984cited by this paper
• Cerebral Glucose Metabolism in Parkinson’s Disease

  1984cited by this paper
• A new headholder for PET, CT, and NMR imaging.

  1984cited by this paper
• Epidemiology of parkinsonism: Incidence, classification, and mortality

  1984cited by this paper
• Inferior parietal lobule. Divergent architectonic asymmetries in the human brain.

  1984cited by this paper
• Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.

  1984cited by this paper
• Multiple Contrasts and Ordered Bonferroni Procedures

  1984cited by this paper
• Apparent discrepancy between single-unit activity and [14C]deoxyglucose labeling in optic tectum of the rattlesnake.

  1983cited by this paper
• Metabolic effects of unilateral lesion of the substantia nigra

  1981cited by this paper
• Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects

  1981cited by this paper
• A cortical network for directed attention and unilateral neglect

  1981cited by this paper
• Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement.

  1980cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• Parkinsonism

  1967cited by this paper
• STRIATO-NIGRAL DEGENERATION.

  1964cited by this paper
• STRIATO-NIGRAL DEGENERATION.

  1964cited by this paper
• An Introduction to Multivariate Statistical Analysis

  1959cited by this paper
• Pithecanthropus in Peking

  1945cited by this paper
• Variation in

  year unknowncited by this paper

• Molecular connectivity studies of cerebral glucose metabolism and blood flow: a scoping review.

  2026cites this paper
• Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

  2026cites this paper
• Current Status of α-Synuclein Biomarkers and the Need for α-Synuclein PET Tracers

  2025cites this paper
• Novel insights into relationships between metabolic covariance patterns of FDG-PET data and clinical status in Parkinson's disease using partial least squares correlation analysis

  2025influential citation
• Parkinsonism disrupts the balance between excitatory and inhibitory activity within the primary motor cortex during movement.

  2025cites this paper
• Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson's disease.

  2025cites this paper
• Metabolomics in Parkinson’s Disease and Correlation with Disease State

  2025cites this paper
• Biomarkers and neuroimaging markers in Parkinson’s disease

  2025cites this paper
• Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach

  2025cites this paper
• Tremor management strategies in Parkinson's disease: optimizing patient care.

  2025cites this paper
• Metabolic network remodeling and AI-driven precision diagnostics in geriatric Parkinson's disease: Advances in multimodal imaging.

  2025cites this paper
• Monitoring Parkinson’s Disease In-the-Wild

  2025cites this paper
• Cortical modulations before lower limb motor blocks are associated with freezing of gait in Parkinson's disease: an EEG source localization study.

  2024cites this paper
• PET-based brain molecular connectivity in neurodegenerative disease

  2024cites this paper
• Individual‐specific metabolic network based on 18F‐FDG PET revealing multi‐level aberrant metabolisms in Parkinson's disease

  2024influential citation
• Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease.

  2024cites this paper
• Pathophysiology of Motor Control Abnormalities in Parkinson's Disease.

  2024cites this paper
• Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies

  2024cites this paper
• Presynaptic terminal integrity is associated with glucose metabolism in Parkinson’s disease

  2024cites this paper
• Neuroimaging Biomarkers in Parkinson's Disease.

  2024cites this paper
• Neuronal threshold functions: Determining symptom onset in neurological disorders

  2024influential citation
• Automatic covariance pattern analysis outperforms visual reading of 18F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) in variant progressive supranuclear palsy

  2023cites this paper
• The effect of Parkin gene S/N 167 polymorphism on resting spontaneous brain functional activity in Parkinson's Disease.

  2023cites this paper
• Disassociation between fluctuation shift over frequency and glucose metabolism in motor cortex of Parkinson's disease: a hybrid PET/fMRI study.

  2023cites this paper
• Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report

  2023cites this paper
• Multimodal imaging study of the 5-HT1A receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia

  2023cites this paper
• Synaptic Density and Glucose Consumption in Patients with <scp>Lewy Body Diseases</scp> : An [ <scp> ¹¹ C </scp> ] <scp>UCB‐J</scp> and [ <scp> <sup>18

  2023cites this paper
• Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET Study

  2023cites this paper
• Pathological Correlates of Cognitive Decline in Parkinson’s Disease: From Molecules to Neural Networks

  2023cites this paper
• Parkinson’s disease progression: Increasing expression of an invariant common core subnetwork

  2023cites this paper
• Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19

  2023cites this paper
• Metabolic imaging and plasticity.

  2022cites this paper
• Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease

  2022cites this paper
• Utility of 18F FDG-PET in Parkinsonism in an African population

  2022cites this paper
• Related to Mild Cognitive and in Patients With Isolated

  2022cites this paper
• Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder

  2022cites this paper
• Clinical and imaging evidence of brain-first and body-first Parkinson's disease.

  2022cites this paper
• Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias

  2022cites this paper
• Update FDG-PET in der Demenzdiagnostik

  2022cites this paper
• Differences in Striatal Metabolism in [18F]FDG PET in Parkinson’s Disease and Atypical Parkinsonism

  2022cites this paper
• Modulation effect of substantia nigra iron deposition and functional connectivity on putamen glucose metabolism in Parkinson's disease

  2022cites this paper
• A multiple-tissue-specific magnetic resonance imaging model for diagnosing Parkinson’s disease: a brain radiomics study

  2022cites this paper
• The Role of Monoaminergic Tones and Brain Metabolism in Cognition in De Novo Parkinson’s Disease

  2022cites this paper
• Parkinson’s Disease-Related Brain Metabolic Pattern Is Expressed in Schizophrenia Patients during Neuroleptic Drug-Induced Parkinsonism

  2022cites this paper
• Lower brain glucose metabolism in normal ageing is predominantly frontal and temporal: A systematic review and pooled effect size and activation likelihood estimates meta‐analyses

  2022cites this paper
• The convergent and divergent patterns in brain perfusion between Alzheimer's disease and Parkinson's disease with dementia: An ASL MRI study

  2022cites this paper
• Parkinson’s Disease

  2021cites this paper
• Mild cognitive impairment and abnormal brain metabolic expression in idiopathic REM sleep behavior disorder.

  2021cites this paper
• Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.

  2021cites this paper
• Cognitive and Behavior Deficits in Parkinson’s Disease with Alteration of FDG-PET Irrespective of Age

  2021cites this paper
• The reconfiguration pattern of individual brain metabolic connectome for Parkinson's disease identification

  2021cites this paper
• Using computerized spiral analysis to evaluate deep brain stimulation outcomes in Parkinson disease.

  2021cites this paper
• The Molecular Neuroimaging of Tremor

  2021cites this paper
• Exploring brain glucose metabolic patterns in cognitively normal adults at risk of Alzheimer’s disease: A cross-validation study with Chinese and ADNI cohorts

  2021cites this paper
• Modulating brain networks associated with cognitive deficits in Parkinson’s disease

  2021cites this paper
• Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review

  2021cites this paper
• Stimulation of the Subthalamic Nucleus Changes Cortical-Subcortical Blood Flow Patterns During Speech: A Positron Emission Tomography Study

  2021cites this paper
• From Positron to Pattern: A Conceptual and Practical Overview of 18F-FDG PET Imaging and Spatial Covariance Analysis

  2020cites this paper
• Use of Nuclear Medicine Molecular Neuroimaging to Model Brain Molecular Connectivity

  2020cites this paper
• Use of positron-emission tomography as a diagnostic and differential diagnostic tool in parkinsonian syndromes

  2020cites this paper
• PET and SPECT Imaging in Atypical Parkinsonian Syndromes

  2020cites this paper
• The Role of Imaging Modalities in the Diagnosis of Parkinsons disease

  2020cites this paper
• Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease.

  2020cites this paper
• Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine

  2020cites this paper
• A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder.

  2019cites this paper
• [18F]FDG-PET/CT in Movement Disorders

  2019cites this paper
• Combined 18F-fluorodeoxyglucose positron emission tomography and event-related potentials study of the cognitive impairment mechanisms in Parkinson's disease.

  2019cites this paper
• Role of Inflammation in Depression and Treatment Implications.

  2019cites this paper
• Hybrid PET-MRI Applications in Movement Disorders.

  2019cites this paper
• Connectivity‐based selection of optimal deep brain stimulation contacts: A feasibility study

  2019cites this paper
• Coordinate based meta-analysis of motor functional imaging in Parkinson’s: disease-specific patterns and modulation by dopamine replacement and deep brain stimulation

  2019cites this paper
• Functional Alteration of Cerebello–Cerebral Coupling in an Experimental Mouse Model of Parkinson’s Disease

  2019cites this paper
• Visual hallucinations, thalamocortical physiology and Lewy Body Disease: A Review.

  2019cites this paper
• Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease

  2019cites this paper
• Predicting the Post-therapy Severity Level (UPDRS-III) of Patients With Parkinson's Disease After Drug Therapy by Using the Dynamic Connectivity Efficiency of fMRI

  2019cites this paper
• Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson’s Disease, Atypical Parkinsonisms, and Other Movement Disorders

  2019cites this paper
• Comparison of Count Normalization Methods for Statistical Parametric Mapping Analysis Using a Digital Brain Phantom Obtained from Fluorodeoxyglucose-positron Emission Tomography

  2019cites this paper
• PET/CT in Brain Disorders

  2019influential citation
• Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts

  2019cites this paper
• Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates.

  2019cites this paper
• Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis

  2019cites this paper
• Biomarkers in Parkinson disease: studies on clinical, radiological and biological biomarkers

  2018cites this paper
• Cortical response to levodopa in Parkinson's disease patients with dyskinesias

  2018cites this paper
• FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease

  2018influential citation
• Identifying mild-moderate Parkinson's disease using whole-brain functional connectivity.

  2018cites this paper
• The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson's disease.

  2018cites this paper
• Altered thalamic glucose metabolism in cerebellar projections in Parkinson’s disease

  2018cites this paper
• In Vivo Positron Emission Tomography of Extrastriatal Non-Dopaminergic Pathology in Parkinson Disease

  2018cites this paper
• Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18F‐FDG PET imaging

  2018cites this paper
• The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease

  2018cites this paper
• Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease

  2018cites this paper
• Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease

  2018cites this paper
• The Role of Imaging Modalities in the Diagnosis of Parkinson's disease

  2018cites this paper
• Impact of Global Mean Normalization on Regional Glucose Metabolism in the Human Brain

  2018cites this paper
• Deficient supplementary motor area at rest: Neural basis of limb kinetic deficits in Parkinson's disease

  2018cites this paper
• Molecular Imaging of Extrapyramidal Movement Disorders.

  2017cites this paper
• A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016)

  2017cites this paper
• Structural and Functional Network Dysfunction in Parkinson Disease.

  2017cites this paper
• [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].

  2017cites this paper
• Impaired synaptic function is linked to cognition in Parkinson's disease

  2017cites this paper